Protein-bound paclitaxel - PMC

Result Filters

You searched 8+ million full text articles

Try this search in 34+ million citations and abstracts

PMC Full-Text Search Results

Items: 1 to 20 of 33016

<< First< Prev

Page of 1651

Next >Last >>

Select item 87718501.

SOX8 Affects Tumoral SPARC Expression by Regulating EZH2 to Attenuate Effectiveness of albumin-bound paclitaxel in PDAC

Shuai Yuan, Jie Xu, Bodong Zhou, Yizhang Zhou, Mingxiao Lang, Junli Cao, Zhe Liu, Shengyu Yang, Song Gao, Jihui Hao

Int J Biol Sci. 2022; 18(3): 911–922. Published online 2022 Jan 1. doi: 10.7150/ijbs.64752

PMCID:: PMC8771850

Article PDF–2.8M

Select item 99795652.

Study on the thermal stability of nab-paclitaxel during hyperthermic intraperitoneal chemotherapy

Jingjing Zhang, Luya Li, Jintuo Yin, Xidong Zhang, Ying Zheng, Rui Feng

BMC Pharmacol Toxicol. 2023; 24: 13. Published online 2023 Mar 1. doi: 10.1186/s40360-023-00653-2

PMCID:: PMC9979565

Article PDF–2.1M

Select item 49442693.

Phase I/II dose-finding study of nanoparticle albumin-bound paclitaxel (nab®-Paclitaxel) plus Cisplatin as Treatment for Metastatic Nasopharyngeal Carcinoma

Yan Huang, Wenhua Liang, Yunpeng Yang, Liping Zhao, Hongyun Zhao, Xuan Wu, Yuanyuan Zhao, Yang Zhang, Li Zhang

BMC Cancer. 2016; 16: 464. Published online 2016 Jul 13. doi: 10.1186/s12885-016-2517-5

PMCID:: PMC4944269

Article PDF–1.4M

Select item 53700464.

Nanoparticle albumin-bound paclitaxel as neoadjuvant chemotherapy of breast cancer: a systematic review and meta-analysis

Yu Zong, Jiayi Wu, Kunwei Shen

Oncotarget. 2017 Mar 7; 8(10): 17360–17372. Published online 2017 Jan 3. doi: 10.18632/oncotarget.14477

PMCID:: PMC5370046

Article PDF–1.0M

Select item 88664445.

Albumin-Bound Paclitaxel: Worthy of Further Study in Sarcomas

Zhichao Tian, Weitao Yao

Front Oncol. 2022; 12: 815900. Published online 2022 Feb 10. doi: 10.3389/fonc.2022.815900

PMCID:: PMC8866444

Article PDF–714K

Select item 54154776.

Efficacy and safety of weekly intravenous nanoparticle albumin‐bound paclitaxel for non‐small cell lung cancer patients who have failed at least two prior systemic treatments

Jianchun Duan, Yueqin Hao, Rui Wan, Sifan Yu, Hua Bai, Tongtong An, Jun Zhao, Zhijie Wang, Minglei Zhuo, Jie Wang

Thorac Cancer. 2017 May; 8(3): 138–146. Published online 2017 Mar 17. doi: 10.1111/1759-7714.12413

PMCID:: PMC5415477

Article PDF–813K

Select item 38831287.

Phase II Trial of Weekly Nanoparticle Albumin-Bound Paclitaxel With Carboplatin and Trastuzumab as First-line Therapy for Women With HER2-Overexpressing Metastatic Breast Cancer

Alison K. Conlin, Andrew D. Seidman, Ariadne Bach, Diana Lake, Maura Dickler, Gabriella D’Andrea, Tiffany Traina, Michael Danso, Adam M. Brufsky, Mansoor Saleh, Alicia Clawson, Clifford A. Hudis

Clin Breast Cancer. Author manuscript; available in PMC 2014 Jan 7.

Published in final edited form as: Clin Breast Cancer. 2010 Aug 1; 10(4): 10.3816/CBC.2010.n.036. doi: 10.3816/CBC.2010.n.036

PMCID:: PMC3883128

Article PDF–385K

Select item 80811828.

A novel preparative method for nanoparticle albumin-bound paclitaxel with high drug loading and its evaluation both in vitro and in vivo

Yue Gao, Jingxue Nai, Zhenbo Yang, Jinbang Zhang, Siyu Ma, Yumei Zhao, Hui Li, Jiaxin Li, Yang Yang, Meiyan Yang, Yuli Wang, Wei Gong, Fanglin Yu, Chunsheng Gao, Zhiping Li, Xingguo Mei

PLoS One. 2021; 16(4): e0250670. Published online 2021 Apr 28. doi: 10.1371/journal.pone.0250670

PMCID:: PMC8081182

Article PDF–4.1M

Select item 91887009.

Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer

Huan Wang, Lingyun Fan, Xia Wu, Yimin Han

BMC Womens Health. 2022; 22: 224. Published online 2022 Jun 11. doi: 10.1186/s12905-022-01794-y

PMCID:: PMC9188700

Article PDF–1.0M

Select item 857266310.

Clinical pharmacokinetics of paclitaxel monotherapy: an updated literature review

Tore B. Stage, Troels K. Bergmann, Deanna L. Kroetz

Clin Pharmacokinet. Author manuscript; available in PMC 2021 Nov 7.

Published in final edited form as: Clin Pharmacokinet. 2018 Jan; 57(1): 7–19. doi: 10.1007/s40262-017-0563-z

PMCID:: PMC8572663

Article PDF–1.2M

Select item 675409511.

Clinical Benefit of Nanoparticle Albumin-Bound-Paclitaxel in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Resistant to Cremophor-Based Paclitaxel or Docetaxel

Jessica Ley, Tanya M. Wildes, Kristin Daly, Peter Oppelt, Douglas Adkins

Med Oncol. Author manuscript; available in PMC 2019 Sep 20.

Published in final edited form as: Med Oncol. 2017 Feb; 34(2): 28. Published online 2017 Jan 11. doi: 10.1007/s12032-017-0884-7

PMCID:: PMC6754095

Article PDF–671K

Select item 558357212.

Nano albumin bound-paclitaxel in pancreatic cancer: Current evidences and future directions

Guido Giordano, Massimo Pancione, Nunzio Olivieri, Pietro Parcesepe, Marianna Velocci, Tania Di Raimo, Luigi Coppola, Giuseppe Toffoli, Mario Rosario D’Andrea

World J Gastroenterol. 2017 Aug 28; 23(32): 5875–5886. Published online 2017 Aug 28. doi: 10.3748/wjg.v23.i32.5875

PMCID:: PMC5583572

Article PDF–1.1M

Select item 875670213.

Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study

Zhichao Tian, Shuping Dong, Yang Yang, Shilei Gao, Yonghao Yang, Jinpo Yang, Peng Zhang, Xin Wang, Weitao Yao

BMC Cancer. 2022; 22: 56. Published online 2022 Jan 12. doi: 10.1186/s12885-022-09176-1

PMCID:: PMC8756702

Article PDF–1.4M

Select item 797837514.

Cell metabolomics analyses revealed a role of altered fatty acid oxidation in neurotoxicity pattern difference between nab-paclitaxel and solvent-based paclitaxel

Jhih-Wei Huang, Ching-Hua Kuo, Han-Chun Kuo, Jin-Yuan Shih, Teng-Wen Tsai, Lin-Chau Chang

PLoS One. 2021; 16(3): e0248942. Published online 2021 Mar 19. doi: 10.1371/journal.pone.0248942

PMCID:: PMC7978375

Article PDF–1.1M

Select item 1073128915.

Efficacy and safety of camrelizumab combined with albumin-bound paclitaxel as third- or later-line regimen in patients with advanced non-small cell lung cancer

Jianfeng Zhu, Yanyan Yu, Jiaqi Mei, Shiyao Chen, Jiufei Li, Sicong Jiang

Front Immunol. 2023; 14: 1278573. Published online 2023 Dec 6. doi: 10.3389/fimmu.2023.1278573

PMCID:: PMC10731289

Article PDF–1.3M

Select item 628426016.

Tolerance, Variability and Pharmacokinetics of Albumin-Bound Paclitaxel in Chinese Breast Cancer Patients

Qingmei Li, Hong Zhang, Xiaoxue Zhu, Chengjiao Liu, Min Wu, Cuiyun Li, Xiaojiao Li, Lei Gao, Yanhua Ding

Front Pharmacol. 2018; 9: 1372. Published online 2018 Nov 29. doi: 10.3389/fphar.2018.01372

PMCID:: PMC6284260

Article PDF–2.0M

Select item 754825517.

Clinical outcomes of neoadjuvant chemotherapy for patients with breast cancer: Tri-weekly nanoparticle albumin-bound paclitaxel followed by 5-fluorouracil, epirubicin, and cyclophosphamide: a retrospective observational study

Masato Shizuku, Masahiro Shibata, Yoshimi Shimizu, Dai Takeuchi, Yutaka Mizuno

Nagoya J Med Sci. 2020 Aug; 82(3): 457–467. doi: 10.18999/nagjms.82.3.457

PMCID:: PMC7548255

Article PDF–700K

Select item 923785318.

Adverse Event Profile for Nanoparticle Albumin-Bound Paclitaxel Compared With Solvent-Based Taxanes in Solid-Organ Tumors: A Systematic Review and Meta-Analysis of Randomized Clinical Trials

Fei He, Jiaxuan Liu, Xin Shen, Zijing Wang, Qiao Li, Guohui Li

Ann Pharmacother. 2022 Aug; 56(8): 898–909. Published online 2021 Dec 28. doi: 10.1177/10600280211058385

PMCID:: PMC9237853

Article PDF–4.9M

Select item 286265719.

Phase I and Pharmacokinetic Study of ABI-007, Albumin-bound Paclitaxel, Administered Every 3 Weeks in Japanese Patients with Solid Tumors

Kazuhiko Yamada, Noboru Yamamoto, Yasuhide Yamada, Toru Mukohara, Hironobu Minami, Tomohide Tamura

Jpn J Clin Oncol. 2010 May; 40(5): 404–411. Published online 2010 Feb 4. doi: 10.1093/jjco/hyp192

PMCID:: PMC2862657

Article PDF–176K

Select item 286038620.

Phase I and pharmacokinetic trial of carboplatin and albumin-bound paclitaxel, ABI-007 (Abraxane^®) on three treatment schedules in patients with solid tumors

Thomas E. Stinchcombe, Mark A. Socinski, Christine M. Walko, Bert H. O’Neil, Frances A. Collichio, Anastasia Ivanova, Hua Mu, Michael J. Hawkins, Richard M. Goldberg, Celeste Lindley, E Claire Dees

Cancer Chemother Pharmacol. Author manuscript; available in PMC 2010 Apr 27.

Published in final edited form as: Cancer Chemother Pharmacol. 2007 Oct; 60(5): 759–766. Published online 2007 Feb 7. doi: 10.1007/s00280-007-0423-x

PMCID:: PMC2860386

Article PDF–446K

<< First< Prev

Page of 1651

Next >Last >>

Supplemental Content

Filter your results:

Manage Filters

Find related data

Search details

Recent activity

Clear Turn Off Turn On

Protein-bound paclitaxel (33016)
PMC

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PMC

Result Filters

Article attributes

Text availability

Publication date

Custom date range

Research Funder

Additional filters

Display Settings:

Send to: